[Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results].

PubWeight™: 0.78‹?›

🔗 View Article (PMID 7019771)

Published in Minerva Nefrol on September 25, 1981

Authors

E Imbasciati, L Cagnoli, N Case, S Pasquali, G Di Filippo, D Limido, L Cornalba, T Volpini, C Pozzi, P Zuccelli, C Ponticelli

Articles by these authors

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med (1996) 5.46

Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet (1999) 3.51

On the origin and domestication history of Barley (Hordeum vulgare). Mol Biol Evol (2000) 2.94

Living alone after myocardial infarction. Impact on prognosis. JAMA (1992) 2.88

Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1984) 2.26

A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol (1998) 2.21

Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int (1997) 2.17

Hypnosis as sole anaesthesia for skin tumour removal in a patient with multiple chemical sensitivity. Anaesthesia (2013) 2.05

The barley Hooded mutation caused by a duplication in a homeobox gene intron. Nature (1995) 1.86

Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int (2007) 1.86

A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1989) 1.83

A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int (1995) 1.74

Cloning, mapping and expression analysis of barley MADS-box genes. Plant Mol Biol (2000) 1.72

Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. DIA-QOL Group. Nephrol Dial Transplant (1999) 1.57

Reversible acute renal failure from gross haematuria due to glomerulonephritis: not only in IgA nephropathy and not associated with intratubular obstruction. Nephrol Dial Transplant (1995) 1.57

Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism. Nephrol Dial Transplant (1996) 1.55

"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int (1996) 1.49

High prevalence of silent gallstone disease in dialysis patients. Nephron (1994) 1.45

Gitelman syndrome: pathophysiological and clinical aspects. QJM (2010) 1.39

Comparison of three different tests for assessment of hepatitis C virus in dialysis patients. Perit Dial Int (1995) 1.39

Microscopic hematuria diagnosis and management. Nephron (1996) 1.39

How to manage the dialysis patient with chronic viral hepatitis who is considered for renal transplantation. Nephrol Dial Transplant (1996) 1.38

Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease. J Hypertens (2000) 1.36

Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura. Nephrol Dial Transplant (1997) 1.27

Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clin Pharmacokinet (1976) 1.25

Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. Br Med J (Clin Res Ed) (1987) 1.23

Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients. Medicine (Baltimore) (1985) 1.23

Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis (2001) 1.15

Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med (1986) 1.15

Preliminary evaluation of incremental peritoneal dialysis in 25 patients. Perit Dial Int (2001) 1.15

The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol (1991) 1.13

Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis (2001) 1.13

Renal replacement therapy in the elderly. Q J Med (1989) 1.13

Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects. Nephrol Dial Transplant (1995) 1.11

Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int (1988) 1.11

Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance. Cancer Res (1987) 1.11

High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int (1995) 1.09

Unexpected dilatation of the common bile duct after methyl tertiary butyl ether (MTBE) in rabbits. Possible implications to findings in man. Gut (1989) 1.08

Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis (1999) 1.07

Long-term outcome of Schönlein-Henoch nephritis in the adult. Clin Nephrol (1989) 1.07

An AFLP-based procedure for the efficient mapping of mutations and DNA probes in barley. Genetics (1998) 1.07

A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation. Transplantation (1991) 1.07

Cutaneous abnormalities in uremic patients. Nephron (1985) 1.06

Factor VIII and chronic renal failure. Br Med J (1977) 1.06

Folding and aggregation of designed proteins. Proc Natl Acad Sci U S A (1998) 1.04

Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis (1999) 1.04

Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet (1983) 1.04

Nephronophthisis (medullary cystic disease of the kidney). A study using electron microscopy, immunofluorescence, and a review of the morphological findings. Helv Paediatr Acta (1980) 1.03

Acquired dysfunction due to the circulation of "exhausted" platelets. Am J Med (1980) 1.02

Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients. Semin Nephrol (1987) 1.02

Molecular linkage maps of Vitis vinifera L. and Vitis riparia Mchx. Theor Appl Genet (2002) 1.02

Renal disease in essential mixed cryoglobulinaemia. Long-term follow-up of 44 patients. Q J Med (1981) 1.02

A reconsideration of the domestication geography of tetraploid wheats. Theor Appl Genet (2005) 1.01

High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease. J Intern Med (2013) 1.00

Focal glomerulosclerosis in patients with unilateral nephrectomy. Kidney Int (1983) 1.00

ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study. Nephrol Dial Transplant (1994) 1.00

Renal lesions in familial lecithin-cholesterol acyltransferase deficiency. Ultrastructural heterogeneity of glomerular changes. Am J Nephrol (1986) 0.99

Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors. Transplantation (2001) 0.99

Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: a prospective study. Transplantation (1997) 0.99

Selective and early increase of IL-1 inhibitors, IL-6 and cortisol after elective surgery. Clin Exp Immunol (1991) 0.98

Extracapillary glomerulonephritis with necrotizing vasculitis in D-penicillamine-treated rheumatoid arthritis. Nephron (1983) 0.97

Hepatorenal syndrome. New perspectives in pathogenesis and treatment. Arch Intern Med (1993) 0.96

Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet (1987) 0.95

Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome. Br Med J (Clin Res Ed) (1985) 0.95

Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial. J Pediatr (1988) 0.94

Uremic pruritus: a review. Nephron (1992) 0.94

Steroid pulses and plasmapheresis in the treatment of acute renal failure in multiple myeloma. Proc Eur Dial Transplant Assoc (1980) 0.94

Lymphocyte subpopulations in minimal-change nephropathy. Nephron (1980) 0.93

The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine. Transplantation (1990) 0.93

Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol (1994) 0.93

High-dose methylprednisolone pulses in active lupus nephritis. Lancet (1977) 0.93

Hemolytic uremic syndrome in adults. Arch Intern Med (1980) 0.93

Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years. Lupus (2013) 0.93

Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro. Lupus (1999) 0.92

Lipid abnormalities in maintenance dialysis patients and renal transplant recipients. Kidney Int Suppl (1978) 0.92

Role of the kidney in 'salt and water dependent hypertension' of end-stage disease. Clin Sci (1972) 0.92

Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: a review of 50 cases. Report of the Italien Renal Immunopathology Group. Clin Nephrol (1987) 0.92

Peritoneal dialysis in nondiabetic patients older than 70 years: comparison with patients aged 40 to 60 years. Am J Kidney Dis (1998) 0.91